Targeting ferroptosis protects against experimental (multi)organ dysfunction and death
Samya Van Coillie(Ghent University), Tom Vanden Berghe(VIB-UGent Center for Medical Biotechnology), Geert Dams(University of Antwerp), Koen Augustyns(University of Antwerp), Emily Van San(University of Antwerp), Wannes Weyts(VIB-UGent Center for Medical Biotechnology), Bartosz Wiernicki(Ghent University), Andreas Linkermann(Albert Einstein College of Medicine), Maya Berg(University of Antwerp), Ria Roelandt(Ghent University), Marcus Conrad(Helmholtz Zentrum München), Ludwig V. Lamberts(University of Antwerp), Mohan Rajapurkar(Muljibhai Patel Urological Hospital), Wulf Tonnus(University Hospital Carl Gustav Carus), Behrouz Hassannia(Albert Einstein College of Medicine), Banibrata Mukhopadhyay, Ines Goetschalckx(University of Antwerp), Jelle Huysentruyt(Ghent University), Sze Men Choi(Ghent University), Alexander L.N. van Nuijs(University of Antwerp), Eric A. J. Hoste(University of Pittsburgh), Catalina Dumitrascu(University of Antwerp), An Vermeulen(Ghent University), Peter Vandenabeele(Ghent University), Ruth Seurinck(Ghent University), Irina Ingold(Helmholtz Zentrum München), Yvan Saeys(University College Ghent), Suhas S. Lele(Muljibhai Patel Urological Hospital), Evelyne Meyer(Ghent University)
Cited by 176
Related Papers
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
FSP1 is a glutathione-independent ferroptosis suppressor
|Nature|2019|3.2k
A comparison of single-cell trajectory inference methods
|Nature Biotechnology|2019|1.7k
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
|Nature Reviews Nephrology|2017|1.5k